The possible role of remnant-like particles as a risk factor for sudden cardiac death

International Journal of Legal Medicine

Volumn 110, Issue 4, 1997, Pages 213-219

  Takeichi, S ^a   Nakajima, Y ^a   Osawa, M ^a   Yukawa, N ^a   Saito, T ^a   Seto, Y ^a   Nakano, T ^b   Adachi, M ^b   Jitsukata, K ^c   Horiuchi, K ^c   Wang, T ^d   Nakajima, K ^d  

^a TOKAI UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c SRL INC   (Japan)

^d OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Remnant like particles (RLP); Risk factor; ROC curve; Sudden cardiac death; Triglyceride rich lipoprotein remnants

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; HEART DISEASE; HUMAN; HUMAN TISSUE; JAPAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SUDDEN DEATH;

ADULT; AGED; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MYOCARDIUM; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDES;

EID: 8544235031     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004140050070     Document Type: Article

References (51)

1. Percentage of deaths and chief causes of death. A profile of Tokyo Medical Examiner's office (1996) published by the Tokyo Metropolitan Government
2. Takeichi S, Wakasugi C, Shikata I (1984) Fluidity of cadaveric blood after sudden death: Part I Postmortem fibrinolysis and plasma catecholamine level. Am J Forensic Med Pathol 5:223-227
3. Takeichi S, Wakasugi C, Shikata I (1985) Fluidity of cadaveric blood after sudden death: Part II Mechanism of release of plasminogen activator from blood vessels. Am J Forensic Med Pathol 6:25-29
4. Takeichi S, Tokunaga I, Hayakumo K, Maeiwa M (1986) Fluidity of cadaveric blood after sudden death: Part III Acid-base balance and fibrinolysis. Am J Forensic Med Pathol 7:35-38
5. Frick MH, Dahlén G, Berg K, Valle M, Hekali P (1978) Serum lipids in angiographically assessed coronary atherosclerosis. Chest 73:62-65
6. Kameda K, Matsuzawa Y, Kubo M, Ishikawa K, Maejima I, Yamamura T, Yamamoto A, Tarui S (1984) Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 51:241-249
7. Stampfar MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. New Engl J Med 325: 373-381
8. Sniderman A, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich Jr PO (1980) Association of coronary atherosclerosis with hyperapobetalipoproteinemia. [increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins]. Proc Natl Acad Sci USA 77:604-608
9. Barbir M, Wile D, Trayner I, Aber VR, Thompson GR (1988) High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J 60:397-403
10. Van der Heiden GL, Barboriak JJ, Sasse EA, Yorde DE (1984) Correlation of the extent of coronary occlusion with apo B levels. Application of a new enzyme immunoassay technique for apo B. Atherosclerosis 50:29-33
11. Assmann G, Schulte H (1992) Role of triglycerides in coronary artery disease: lessons from the prospective cardiovascular Münster study. Am J Cardiol 70:10H-13H
12. Phillips NR, Waters D, Havel RJ (1993) Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88:2762-2770
13. Hiserodt JC, Perper JA, Koehler SA, Orchard TJ (1995) A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac deaths. Am J Forensic Med Pathol 16:101-106
14. Davignon J, Cohn JS (1996) Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 124 suppl : S57-S64
15. Fontbonne A, Eschwége E, Cambien F, Richard JL, Ducimetiére P, Thibult N, Warnet JM, Claude JR, Rosselin GE (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304
16. Sata T, Havel RJ. Jones AL (1972) Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 13:757-768
17. Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley RW (1981) Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest 68:1075-1085
18. Fainaru M, Mahley RW, Hamilton RL, Innerarity TL (1982) Structural and metabolic heterogeneity of β-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res 23:702-714
19. Kane JP, Chen GC, Hamilton RL, Hardman DA, Malloy MJ, Havel RJ (1983) Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis 3:47-56
20. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ (1993) Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223:53-71
21. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Murase T (1994) A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscler Thromb 1:30-36
22. Campos E, Nakajima K, Tanaka A, Havel RJ (1992) Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100, J Lipid Res 33:369-380
23. Tomono S, Kawazu S, Kato N, Ono T, Ishii C, Ito Y, Shimizu M, Shimoyama M, Nakano T, Nakajima K (1994) Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb 1:98-102
24. Knöfler R, Nakano T, Nakajima K, Takada Y, Takada A (1995) Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 78:161-171
25. Doi H, Kugiyama K, Ohta Y, Matsumura T, Sugiyama S, Nakano T, Nakajima K (1995) Remnants of chylomicron and VLDL impair endothelium-dependent vasorelaxation. Circulation 92 suppl 1: 1-39
26. Ahmed ANH, Elton RA, Busuttil A (1996) Assessment of myocardial vasculature in chronic alcoholics without established cardiomyopathy. Int J Legal Med 109:167-172
27. Zack F, Terpe H, Hammer U, Wegener R (1996) Fibromuscular dysplasia of coronary arteries as a rare cause of death. Int J Legal Med 108:215-218
28. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Ishikawa T, Nakamura H (1992) A new assay method for remnant lipoproteins and its clinical significance - 1) The quantification of serum RLP-C (remnant-like particle cholesterol) in a fasting state - (in Japanese with English summary) J Jpn Atheroscler Soc 20:79-88
29. Takagi S, Fukuo Y, Seta K, Saito T, Nakajima K, Hasegawa T, Nakajima S, Terashi A (1992) Particle remnants (RLP, Lipo-Z) and lipoproteins in patients with chronic cerebral infarction (in Japanese with English summary). J Jpn Atheroscler Soc 20: 675-679
30. Ichikawa K, Orimo K (1991) Remnant-like particles in various liver diseases (in Japanese with English summary). Kitakanto Med J 41:159-170
31. Hara I, Okazaki M (1986) High-performance liquid chromatography of serum lipoproteins. Methods Enzymol 129:57-78
32. Steinmetz A (1987) Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting. J Lipid Res 28: 1364-1370
33. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
34. Yamamura T (1994) Apolipoprotein E (in Japanese with English summary). Jpn J Clin Med 52:3124-3132
35. Eto M, Sato T, Watanabe K, Iwashima Y, Makino I (1990) Effects of probucol on plasma lipids and lipoproteins m familial hypercholesterolemic patients with and without apolipoprotein E4. Atherosclerosis 84:49-53
36. Naumann HN (1956) Postmortem liver function tests. Am J Clin Pathol 26:495-505
37. Glanville JN (1960) Post-mortem serum cholesterol levels. BMJ 2:1852-1853
38. Enticknap JB (1961) Lipids in cadaver sera after fatal heart attacks. J Clin Pathol 14:496-499
39. Fekete JF, Brunsdon DFV (1974) The use of routine laboratory tests in postmortem examinations. Can Soc Forensic Sci 7: 238-254
40. Hornick CA, Baker HN, Malcom GT, Newman WP, Roheim PS, Strong JP (1988) Lipoproteins and apolipoproteins in postmortem serum. Mod Pathol 1:480-484
41. Särkioja T, Ylä-Herttuala S, Solakivi T, Nikkari T, Hirvonen J (1988) Stability of plasma total cholesterol, triglycerides, and apolipoproteins B and A-I during the early postmortem period. J Forensic Sci 33:1432-1438
42. Sato U, Okuda K (1988) Free glycerol deletion method in TG assay and its clinical application (in Japanese). Rinsyou-Kensa Kiki : Shiyaku 11:97-104
43. Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: Increased risk of fatal myocardial infarction. Blood Press Suppl 4:35-42
44. Sekihara T, Nakano T, Nakajima K (1996) High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery disease on chronic maintenance hemodialysis. Jpn J Nephrol 38:220-228
45. Shimizu H, Mori M, Saito T (1993) An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. Clin Chim Acta 221:191-196
46. Ikewaki K, Shige H, Nakajima K, Nakamura H (1995) Postprandial remnant-like particles and coronary artery disease. Proceedings of the 10th international symposium on atherosclerosis, Montreal, pp 200-202
47. Tanaka A, Ejiri N, Fujinuma Y, Yui K, Tamura M, Nakajima K, Morohoshi M, Fujisawa K, Uchimura I, Numano F (1995) Remnant-like particles and restenosis of coronary arteries after PTCA. Ann NY Acad Sci 748:595-598
48. Sakata K, Miura F, Shirotani M, Yoshida H, Hoshino T, Kurata C, Takada Y, Takada A (1997) Remnant-like particle-cholesterol and vasospastic angina. Atherosclerosis (submitted)
49. Davignon J, Gregg RE, Sing CF (1998) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21
50. Bergeron N, Havel RJ (1996) Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ε4 allele. J Clin Invest 97:65-72
51. Lehtimäki T (1991) Determination of apolipoprotein E phenotypes from stored or postmortem samples. Clin Chim Acta 203: 177-182